Cover Story
Capitol Hill
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.
In Brief
Clinical Roundup
Drugs & Targets
Trending Stories
- As Trump’s second term nears, Republican support for NIH is at a low point
By stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research - Cedars-Sinai spearheads first national certification program for COE staff at cancer centers
- Trump 2016: A look back at the 45th president’s impact on oncology
- When cigarette filters were made of asbestos
- Patient navigation benefits health systems, improves care
Initial data presented at the White House come a year after CMS payment began - Larry Einhorn reflects on his pioneering work on platinum-based chemotherapy at the AACI/CCAF annual meeting